Bryan B. Molloy - Concepedia

Author

Bryan B. Molloy

Eli Lilly (United States)

Also Known As

B B Molloy, B. B. MOLLOY, B. B. Molloy, B.B. Molloy, BRYAN B. MOLLOY, Bryan B Molloy, Bryan B. Molloy

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Bryan B. Molloy is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	1.9K
2	Natural Sciences	12	13	376
3	Engineering	4	4	121
4	Health Sciences	2	2	72
5	Humanities	1	1	16

Bryan B. Molloy

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine David T. Wong, Jong S. Horng, Frank P. Bymaster, Life Sciences Serotonin UptakeMedicinePsychopharmacologyPharmacotherapyPharmacology	1974	475
A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine. Dawn M. Wong, Frank P. Bymaster, Jong S. Horng, Journal of Pharmacology and Experimental Therapeutics	1975	370
Effect of an uptake inhibitor on serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110140) Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy Life Sciences Serotonin MetabolismMedicinePsychopharmacologyNeuropharmacologyExperimental Pharmacology	1974	206
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy European Journal of Pharmacology MedicinePharmacologyPsychopharmacologyNeuropharmacologyNeuroscience	1975	109
Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy PubMed Brain SerotoninPsychopharmacologyPharmacotherapyLilly 110140Experimental Pharmacology	1975	101
Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats Ray W. Fuller, Harold D. Snoddy, Bryan B. Molloy Life Sciences Social SciencesAdrenal GlandSerotonin Neural PathwayNeuroendocrine MechanismHypothalamic Peptide	1976	77
The effects of quipazine on serotonin metabolism in rat brain Ray W. Fuller, Harold D. Snoddy, Kenneth W. Perry, Life Sciences Serotonin MetabolismNeurophysiologyNeuroanatomyMedicinePhysiology	1976	71
Selective inhibition of monoamine oxidase in rat brain mitochondria Ray W. Fuller, Betty J. Warren, Bryan B. Molloy Biochemical Pharmacology NeurophysiologyMedicineNeuropharmacologyMonoamine OxidaseNeuroprotection	1970	60
Aranotin and related metabolites. II. Isolation, characterization, and structures of two new metabolites Norbert Neuss, R. Nagarajan, Bryan B. Molloy, Tetrahedron Letters Chemical BiologyBiochemistryNatural SciencesSecondary MetaboliteNatural Product Biosynthesis	1968	60
Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo Ray W. Fuller, Harold D. Snoody, Norman R. Mason, European Journal of Pharmacology NeurophysiologyMedicinePsychopharmacologyNeuropharmacologySerotonin Turnover	1978	59

Page 1